Literature DB >> 7422397

Creatine kinase isoenzymes in high-risk infants.

R A Cuestas.   

Abstract

Serial measurements of serum creatine kinase isoenzymes were done from birth to 15 days of age in healthy premature infants, infants with perinatal or neonatal asphyxia and infants without asphyxia but with miscellaneous problems. Serum brain-specific fraction of creatine kinase (CK-BB) activity was higher in cord than in maternal serum (P < 0.01). In healthy infants, the serum activity of heart- and muscle-specific fractions of creatine kinase increased after birth, reached a plateau between 12 and 48 hr, and then declined, whereas the serum CK-BB decreased rapidly after birth and remained stable between 6 hr and 15 days. Compared to controls, infants with severe asphyxia and neurologic damage had a significant rise in serum CK-BB (P < 0.001). When the peak CK-BB level exceeded 35 IU/liter the mortality was high (83%). The increase in CK-BB was not observed in infants who received pentobarbital shortly after the episode of asphyxia. Diseases of the lung, kidneys, gastrointestinal tract, and abruptio placentae were not associated with increases of serum creatine kinase isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7422397     DOI: 10.1203/00006450-198008000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Creatine phosphokinase isoenzyme activity in umbilical artery, umbilical vein and capillary blood of newborn infants at term.

Authors:  M Amato; E Aegerter; W Reiber; H Schneider
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

2.  Serum creatine phosphokinase (CPK) isoenzymes in perinatal asphyxia.

Authors:  M M Thangavel; P L Chordia; N Rudolph
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

3.  First day serum creatine kinase BB isoenzyme in high-risk infants.

Authors:  R A Primhak; E Simmonds
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

4.  Prognostic value of creatine kinase BB-isoenzyme in high risk newborn infants.

Authors:  V J Ruth
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

5.  Umbilical cord serum creatine kinase BB in the diagnosis of brain damage in the newborn: problems in interpretation.

Authors:  B Kumpel; S M Wood; P P Anthony; F S Brimblecombe
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

Review 6.  Evaluating Potential Biomarkers of Health and Performance in Veal Calves.

Authors:  Francesca Marcato; Henry van den Brand; Bas Kemp; Kees van Reenen
Journal:  Front Vet Sci       Date:  2018-06-21

7.  Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy.

Authors:  Sunju Park; Breanne Maloney; Michele Caggana; Norma P Tavakoli
Journal:  Muscle Nerve       Date:  2022-04-06       Impact factor: 3.852

8.  Assessment of catabolic state in infants with the use of urinary titin N-fragment.

Authors:  Sachiyo Fukushima; Nobuto Nakanishi; Kazumichi Fujioka; Kenichi Suga; Taku Shirakawa; Kayo Osawa; Kanako Hara; Rie Tsutsumi; Maki Urushihara; Ryuji Nakagawa; Hiroyuki Awano; Jun Oto; Hiroshi Sakaue; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Res       Date:  2021-07-17       Impact factor: 3.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.